PMCB

PHARMACYTE BIOTECH INC

PMCB·71715X203·US·Common Stock·Healthcare - Biotechnology-13D/G

PMCB (PHARMACYTE BIOTECH INC) is held by 19 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($218,203), GEODE CAPITAL MANAGEMENT, LLC ($95,681), VANGUARD CAPITAL MANAGEMENT LLC ($43,719). Net institutional sentiment: Mixed.

19
Holders
$565,327
Total Value
39% (18)
Consensus
7 buying - 11 selling
13F: Insider & Congress: Updated regularly
PMCB

Smart Money Verdict

View all
Loading verdict
Held by 19 funds

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Jan 7, 2026 · Activists Feb 13, 2026 · Congress none

ActivistMPMitchell P. Kopin5.0%Feb 13, 2026
InsiderSJSCHECHTER JONATHANBuy $17KJan 7, 2026
InsiderSJSilverman JoshuaBuy $33KJan 7, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
283,381(-21.2%)$218,2030.0%-49.77%
0
Decreased
124,247(-36.5%)$95,6810.0%-80.96%
0
Increased
56,778(+10.3%)$43,7190.0%-48.98%
15
New
44,853$34,5360.0%-52.58%
30
Decreased
37,987(-32.8%)$29,2500.0%-79.09%
0
Decreased
34,180(-34.7%)$26,3190.0%-48.92%
0
Decreased
32,624(-8.4%)$25,1200.0%-78.31%
0
Increased
30,064(+160.8%)$23,1490.0%-51.37%
21
Decreased
26,926(-0.3%)$20,7330.0%-86.90%
0
Unchanged
23,452$18,0580.0%-48.58%
0
Increased
20,255(+96.4%)$15,6000.0%-50.63%
20
Decreased
15,451(-37.5%)$11,0000.0%-49.29%
0
Decreased
4,142(-8.3%)$3,1890.0%-57.90%
0
Decreased
500(-72.0%)$3850.0%-48.58%
0
Increased
303(+0.3%)$2320.0%-65.88%
8
New
192$1480.0%-52.58%
17
Unchanged
2$20.0%-86.24%
0
Increased
2(+100.0%)$20.0%-60.72%
12
Unchanged
1$10.0%-62.74%
0
Exited
0(-100.0%)$25,0000.0%+8.45%
0

Showing 1-20 of 22

1 / 2
PMCBPMCBPHARMACYTE BIOTECH INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used